Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites

Treatment of inflammatory disorders with glucocorticoids (GCs) is often accompanied by severe adverse effects. Application of GCs via nanoparticles (NPs), especially those using simple formulations, could possibly improve their delivery to sites of inflammation and therefore their efficacy, minimisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Napp, Joanna, Markus, M. Andrea, Heck, Joachim G., Dullin, Christian, Möbius, Wiebke, Gorpas, Dimitris, Feldmann, Claus, Alves, Frauke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299685/
https://www.ncbi.nlm.nih.gov/pubmed/30613305
http://dx.doi.org/10.7150/thno.28324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299685/
https://www.ncbi.nlm.nih.gov/pubmed/30613305
http://dx.doi.org/10.7150/thno.28324

Ejemplares similares